When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Responsive neurostimulation device - Wikipedia

    en.wikipedia.org/wiki/Responsive_neuro...

    Responsive neurostimulation device is a medical device that senses changes in a person's body and uses neurostimulation to respond in the treatment of disease. The FDA has approved devices for use in the United States in the treatment of epileptic seizures [ 1 ] and chronic pain [ 2 ] conditions.

  3. Childhood dementia - Wikipedia

    en.wikipedia.org/wiki/Childhood_dementia

    By their usual definitions, childhood dementias always cause global neurocognitive decline. In some childhood dementia conditions the child's early development is indistinguishable from their healthy peers, then slows or plateaus before declining. In other childhood dementia disorders, early development may be slower than typical before declining.

  4. Pulsed electromagnetic field therapy - Wikipedia

    en.wikipedia.org/wiki/Pulsed_electromagnetic...

    In 2004, a pulsed electromagnetic field system was approved by the FDA as an adjunct to cervical fusion surgery in patients at high risk for non-fusion. [6] On 8/9 September 2020 the FDA recommended to shift PEMF medical devices from the Class 3 category to a Class 2 status. [7]

  5. How a new FDA-approved drug can — and can’t — help people ...

    www.aol.com/fda-approved-drug-t-help-121600044.html

    In early 2023, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a new Alzheimer’s drug called Leqembi. (Biogen, a biotechnology company, and Eisai, a pharmaceutical ...

  6. Neurostimulation - Wikipedia

    en.wikipedia.org/wiki/Neurostimulation

    Modern cochlear implant research started in the 1960s and 1970s. In 1961, a crude single electrode device was implanted in two deaf patients and useful hearing with electric stimulation was reported. The first FDA approved complete single channel device was released in 1984. [25]

  7. US FDA approves Sanofi-AstraZeneca's preventive RSV ... - AOL

    www.aol.com/news/us-fda-approves-sanofi-astra...

    The therapy, branded Beyfortus, was approved for preventing lower respiratory tract disease in infants born during or entering their first RSV season, and in children up to 24 months of age who ...

  8. Who is eligible for the new FDA-approved Alzheimer's drug? - AOL

    www.aol.com/lifestyle/explainer-eligible-fda...

    With standard FDA approval, Medicare has said it will reimburse patients for the treatment as long as their doctors collect data and submit it to a free health agency database, known as a registry.

  9. Paro (robot) - Wikipedia

    en.wikipedia.org/wiki/Paro_(robot)

    [3] [4] Paro was classified as a Class 2 medical device by U.S. regulators in fall 2009. [2] Paro has been used primarily in care facilities, especially as a form of therapy for dementia patients. [5] After a study was conducted to see the effects of robots on children with autism spectrum disorder, it appeared that there are numerous benefits ...